Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain

Journal of Pediatrics

Volumn 142, Issue 4, 2003, Pages 373-376

  Dougherty, Matt ^a   DeBaun, Michael R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; LORAZEPAM; METHADONE; MIDAZOLAM; MORPHINE; OPIATE DERIVATIVE;

ARTICLE; CANCER PAIN; CANCER PATIENT; CHILD; CLINICAL ARTICLE; DRUG USE; DYING; HUMAN; NEUROPATHIC PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TERMINAL CARE; TERMINAL DISEASE;

EID: 0037396855     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2003.107     Document Type: Article

References (12)

1. Storey P. Symptom control in advanced cancer. Semin Oncol 1994;21:748-53.
2. Pud D EE, Spitzer A, Adler R, Fried G, Yarnitsky D. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 1998;75;349-54.
3. Wolfe JGH, Klar N, Levin S, Ellenbogen J, Salem-Schatz S, Emanuel E, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000;342:326-33.
4. Crosby VWA, Corcoran R. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manag 2000;19:35-9.
5. Martin LHN, Hagen NA. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J Pain Symptom Manag 1997;14:99-117.
6. Mercadante SCA, Calderone L. Rapid switching from morphine to methadone in cancer patients with poor response to morphine. 1999;17:3307-12.
7. Caraceni A, Zecca E, Martini C, DeConno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manag 1999;17:441-5.
8. Bruera E, Neumann C. Role of methadone in management of pain in cancer patients. Oncology 1999;13:1275-93.
9. Felsby SNJ, Arendt-Neilsen L, Jensen T. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1996;64:283-91.
10. Eisenberg EPD. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine? Pain 1998;74:337-9.
11. Mercadante SCA, Agnello A, Barresi L. Methadone response in advanced cancer patients with pain followed at home. J Pain Symptom Manag 1999;18:188-92.
12. Gagnon B, Bruera E. Differences in the rations of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain. J Pain Symptom Manag 1999;18:120-5.